2019
DOI: 10.1038/s41429-019-0211-y
|View full text |Cite
|
Sign up to set email alerts
|

2-Pyrazol-1-yl-thiazole derivatives as novel highly potent antibacterials

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(1 citation statement)
references
References 17 publications
0
1
0
Order By: Relevance
“…2-Iminothiazolines are biologically active compounds represented by selective cannabinoid receptor type 2 (CB2) agonists, [1][2][3][4] carbonic anhydrase (CA), cyclooxygenase (COX) and lipoxygenase (LOX) inhibitors, [5][6][7][8][9] anticancer [10,11] and antithrombotic agents, [12] HIV1 reverse transcriptase inhibitors [13] and fungicides (Figure 1). [14] Similarly, related 2-aminothiazoles showed anticancer, [15][16][17][18] antibacterial, [19] anticonvulsant, antidiabetic, antihypertensive, anti-inflammatory, antiviral, antimicrobial and neuroprotective activities. [20] They are represented by the marketed antiviral and antiparasitic drug Nitazoxanide, the β3 adrenergic receptor agonist Mirabegron, the antileukemic Dasatinib and the antiulcer Famotidine (Figure 1).…”
Section: Introductionmentioning
confidence: 99%
“…2-Iminothiazolines are biologically active compounds represented by selective cannabinoid receptor type 2 (CB2) agonists, [1][2][3][4] carbonic anhydrase (CA), cyclooxygenase (COX) and lipoxygenase (LOX) inhibitors, [5][6][7][8][9] anticancer [10,11] and antithrombotic agents, [12] HIV1 reverse transcriptase inhibitors [13] and fungicides (Figure 1). [14] Similarly, related 2-aminothiazoles showed anticancer, [15][16][17][18] antibacterial, [19] anticonvulsant, antidiabetic, antihypertensive, anti-inflammatory, antiviral, antimicrobial and neuroprotective activities. [20] They are represented by the marketed antiviral and antiparasitic drug Nitazoxanide, the β3 adrenergic receptor agonist Mirabegron, the antileukemic Dasatinib and the antiulcer Famotidine (Figure 1).…”
Section: Introductionmentioning
confidence: 99%